Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar® (sorafenib) and Stivarga® (...
March 02 2015 - 7:45AM
CINCINNATI, March 2, 2015 -
Advanced Care Scripts (ACS), a leading specialty pharmacy and
clinical services platform of Omnicare's Specialty Care Group, has
been chosen to dispense Bayer's Nexavar® (sorafenib)
and Stivarga® (regorafenib)
as part of their limited distribution networks.
Nexavar is an anticancer medicine indicated for hepatocellular
carcinoma (HCC), advanced renal cell carcinoma (RCC), and
differentiated thyroid carcinoma (DTC).
Stivarga is indicated for the treatment of
patients with metastatic colorectal cancer who have been previously
treated with fluropyrimidine-, oxaliplatin-, and irinotecan-based
chemotherapy, an anti-VEGF therapy, and, if KRAS wild-type, an
anti-EGFR therapy. Stivarga also treats patients with locally
advanced, unresectable, or metastatic gastrointestinal stromal
tumor who have been previously treated with imatinib mesylate and
sunitinib malate.
ACS has proven experience in successfully managing
and dispensing specialty medications, making it an ideal partner
for pharmaceutical manufacturers. Its expertise in providing
access and reimbursement support enables an efficacious process in
navigating insurance benefits and financial assistance for
patients. ACS services are centrally coordinated to simplify
reimbursement and delivery of these complex treatments, and
increase the speed to therapy for their patient populations.
"We are extremely pleased to be part of the Bayer
specialty pharmacy network," said Dennis Wilson, Vice President and
General Manager of ACS. "As we continue to leverage our
differentiated expertise and service offering within this growing
therapeutic area, we are a compelling pharmacy solution for
patients being prescribed Nexavar and Stivarga. We look
forward to providing comprehensive pharmacy services for these
important oncologic therapies."
About Omnicare Specialty Care
Group
Omnicare Specialty Care Group (SCG) is a division of Omnicare,
Inc., a Fortune 500 company and provider of comprehensive
pharmaceutical services based in Cincinnati, Ohio. Omnicare SCG is
a combination of synergistic tenured companies with a focused
approach to pharmaceutical brand solutions. Together, Omnicare SCG
brings specialists in reimbursement methods, clinicians practiced
in medication therapy management for chronic disease states, and
distribution channel expertise. Solutions are tailored to drive
product access by solving challenges faced by patients and their
caregivers, physicians, payers and manufacturers. Custom programs
are led by a single management team across the organizational
platforms, allowing coordination of resources and assets to support
positive outcomes for our patients. For more information, visit
www.omnicarescg.com.
About Advanced Care
Scripts
Advanced Care Scripts, a specialty
pharmacy, manages and dispenses specialty medications and products
nationwide. It coordinates services beginning with the prescriber
to simplify reimbursement and delivery of biotech therapies used to
treat cancer, infectious diseases, auto-immune disorders, multiple
sclerosis, hemophilia, and other disease states. Its customer
service and comprehensive patient care model provides compliance
and adherence support and cost-effective solutions for all classes
of specialty medications.
# # #
Contact:
Patrick C. Lee
(513) 719-1507
patrick.lee@omnicare.com
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Omnicare via Globenewswire
HUG#1898287